2355225-38-4
2355225-38-4
Chemical Structure
HBV-IN-16
- CAS. Nr.: 2355225-38-4
- Formula:C22H20ClNO4
- Molecular Weight:397.85
IUPAC Name: (1s,3s)-3-(2-(4-(8-chloroquinolin-2-yl)phenoxy)ethoxy)cyclobutane-1-carboxylic acid
InChIKey: UNCSQDWDDTUMNB-MAEOIBBWSA-N
SMILES: ClC1=CC=CC2=C1N=C(C3=CC=C(C=C3)OCCO[C@H]4C[C@H](C4)C(O)=O)C=C2
Biological Activity: HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1)[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HBV-IN-16 | HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
